Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression.

Smith ALW. et al, (2023), CNS Drugs

An online experimental medicine trial on the effect of 28-day simvastatin administration on emotional processing, reward learning, working memory and salivary cortisol in healthy volunteers at risk for depression: OxSTEP protocol.

Waters S. et al, (2023), BJPsych Open, 9

5-HT4 Receptor Agonist Effects on Functional Connectivity in the Human Brain: Implications for Procognitive Action.

de Cates AN. et al, (2023), Biol Psychiatry Cogn Neurosci Neuroimaging

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.

Colwell MJ. et al, (2022), Transl Psychiatry, 12

Acute neural effects of fluoxetine on emotional regulation in depressed adolescents.

Capitão LP. et al, (2022), Psychol Med, 53, 1 - 12

Associations Between Statin Use and Negative Affective Bias During COVID-19: An Observational, Longitudinal UK Study Investigating Depression Vulnerability.

Gillespie AL. et al, (2022), Biol Psychiatry

The Effect of the 5-HT4 Agonist, Prucalopride, on a Functional Magnetic Resonance Imaging Faces Task in the Healthy Human Brain.

de Cates AN. et al, (2022), Front Psychiatry, 13

Déjà-vu? Neural and behavioural effects of the 5-HT4 receptor agonist, prucalopride, in a hippocampal-dependent memory task.

de Cates AN. et al, (2021), Transl Psychiatry, 11

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action.

Murphy SE. et al, (2021), Lancet Psychiatry, 8, 824 - 835

Online behavioural activation during the COVID-19 pandemic decreases depression and negative affective bias.

Ruzickova T. et al, (2021), Psychol Med, 1 - 18

A Translational Perspective on the Anti-Anhedonic Effect of Ketamine and its Neural Underpinnings

PULCU E. et al, (2021), Molecular Psychiatry

How Representative are Neuroimaging Samples? Large-Scale Evidence for Trait Anxiety Differences Between fMRI and Behaviour-Only Research Participants.

Charpentier CJ. et al, (2021), Soc Cogn Affect Neurosci

Translating the promise of 5HT4 receptor agonists for the treatment of depression.

Murphy SE. et al, (2021), Psychol Med, 51, 1111 - 1120

Negative bias in interpretation and facial expression recognition in late life depression: A case control study.

Baruch N. et al, (2021), Int J Geriatr Psychiatry

Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing.

O'Neill RA. et al, (2021), BMC Neurol, 21

An exploration of the pro-cognitive potential of the 5-HT4 agonist, prucalopride, in the healthy human brain

De Cates A. et al, (2021), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 44, S43 - S44

Effects of online behavioural activation on depression during covid-19

Ruzickova T. et al, (2021), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 44, S36 - S37

Neural effects of a single dose of fluoxetine on resting-state functional connectivity in adolescent depression.

Capitão LP. et al, (2020), J Psychopharmacol, 34, 1461 - 1465

Effect of acute citalopram on self-referential emotional processing and social cognition in healthy volunteers.

Hobbs C. et al, (2020), BJPsych Open, 6

Effect of 5-HT4 receptor agonism on memory processing during a functional MRI hippocampal task in humans

DE CATES A. et al, (2020)

Load More

1
2
3
4
5

Include forthcoming?